These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23899875)

  • 1. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
    Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
    Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Stanisavljevic N; Banicevic S; Smiljanic D; Milovanovic B
    Clin Exp Rheumatol; 2018; 36(5):850-855. PubMed ID: 29846156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
    Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
    Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
    Stojanovich L; Djokovic A; Kontic M
    Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort.
    Djokovic A; Stojanovich L; Stanisavljevic N; Djokic S; Filipovic B; Matic P; Milanovic M; Apostolovic S; Saponjski J
    Clin Rheumatol; 2022 May; 41(5):1447-1455. PubMed ID: 35018582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.
    Stojanovich L; Djokovic A; Stanisavljevic N; Zdravkovic M
    Lupus; 2018 Apr; 27(5):858-863. PubMed ID: 29301476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
    Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients.
    Li S; Bai Y; Meng J; Wang Q; Tian X; Li M; Zeng X; Zhao J; Hu C
    Front Immunol; 2023; 14():1107510. PubMed ID: 37122726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antiphospholipid antibodies in patients with neurological symptoms.
    Miesbach W; Gilzinger A; Gökpinar B; Claus D; Scharrer I
    Clin Neurol Neurosurg; 2006 Feb; 108(2):135-42. PubMed ID: 16412834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of antiphospholipid syndrome.
    Rodrigues CE; Carvalho JF; Shoenfeld Y
    Eur J Clin Invest; 2010 Apr; 40(4):350-9. PubMed ID: 20192975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.